, Tracking Stock Market Picks
Enter Symbol:
Poniard Pharmaecuticals, Inc. (PARD) [hlAlert]

down 99.87 %

Poniard Pharmaecuticals, Inc. (PARD) rated Buy with price target $6 by Lazard Capital

Posted on: Monday,  Feb 9, 2009  8:25 AM ET by Lazard Capital

Lazard Capital rated Buy Poniard Pharmaecuticals, Inc. (OTCBB: PARD) on 02/09/2009, when the stock price was $92.80. Since
then, Poniard Pharmaecuticals, Inc. has lost 99.87% as of 08/27/2015's recent price of $0.12.
If you would have followed this Lazard Capital's recommendation on PARD, you would have lost 99.87% of your investment in 2390 days.

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of cancer therapy products. Its lead product candidate is picoplatin, a platinum-based cancer therapy. An intravenous chemotherapeutic agent, picoplatin is designed to overcome platinum resistance in the treatment of solid tumors. The Company initiated a Phase III SPEAR (Study of Picoplatin Efficacy After Relapse) trial of picoplatin in small cell lung cancer. The Company is also conducting separate Phase I/II studies of picoplatin in the treatment of patients with metastatic colorectal cancer and hormone-refractory prostate cancer. NeoRx Manufacturing Group, Inc. is a wholly owned subsidiary of the Company.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/9/2009 8:25 AM Buy
92.80 240.00
as of 12/31/2009
1 Week down  -63.21 %
1 Month down  -69.66 %
3 Months down  -91.44 %
1 YTD down  -72.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy